Who are Pomelo Care's decision-makers?
Pomelo Care's public leadership centers on Marta Bralic Kerns, Isabelle Von Kohorn, MD, PhD, Shyamali Choudhury, Clinical care team. Buying decisions vary by category but generally include executive, clinical, operations, product, compliance, security, and finance stakeholders.
- CEO
- Marta Bralic Kerns
- CTO/key exec
- Isabelle Von Kohorn, MD, PhD
- Founded
- 2021
- Employees
- 201-500 reported range
- HQ
- New York, NY
- Notable
- Private; Series C
- Marta Bralic KernsFounder & CEOFounderLeads Pomelo's virtual value-based care model.
- Isabelle Von Kohorn, MD, PhDChief Medical OfficerCurrent executiveLeads clinical model and outcomes.
- Shyamali ChoudhuryChief Commercial OfficerCurrent executiveLeads payer and employer growth.
- Clinical care teamOB, pediatric, behavioral, and care navigationCurrent functionProvides multidisciplinary virtual care.
Who leads Pomelo Care?
Marta Bralic Kerns, Isabelle Von Kohorn, MD, PhD, Shyamali Choudhury, Clinical care team are the key public leaders in this profile. Their backgrounds indicate where strategy, clinical credibility, operations, product, and commercialization decisions are likely anchored.
Who actually makes buying decisions at Pomelo Care?
For clinical, patient, or payer-facing software, buying decisions usually require executive sponsorship plus clinical, compliance, legal, security, finance, and product review. For GTM, workforce, or back-office tools, operations and finance may lead but compliance and security still gate deployment.
How is Pomelo Care organized as it scales?
Pomelo Care appears organized around product, clinical or healthcare operations, customer growth, compliance, data, and partnerships. Sellers should align outreach to the operational problem they solve instead of starting with only the CEO.
As of June 2026.Sources:Pomelo aboutPomelo $33MPomelo $46M Series B
Pomelo Care — frequently asked questions
